{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:20:21Z","timestamp":1770276021327,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2011\/05805-1"],"award-info":[{"award-number":["2011\/05805-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["141705\/2011-6"],"award-info":[{"award-number":["141705\/2011-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3508-8","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T14:34:01Z","timestamp":1542638041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Interferon-\u03b3 release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Giselle Burlamaqui","family":"Klautau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadijane Val\u00e9ria Ferreira","family":"da Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-6024","authenticated-orcid":false,"given":"Mauro Jos\u00e9 Costa","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Nascimento","family":"Burattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Silva","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"3508_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1586\/14787210.1.3.483","volume":"1","author":"KC Smith","year":"2003","unstructured":"Smith KC, Armitige L. Wanger a. a review of tuberculosis: reflections on the past, present and future of a global epidemic disease. Expert Rev Anti-Infect Ther. 2003;1:483\u201391.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"3508_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJMra1200894","volume":"368","author":"A Zumla","year":"2013","unstructured":"Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med. 2013;368:745\u201355.","journal-title":"N Engl J Med"},{"key":"3508_CR3","unstructured":"World Health Organization. Global tuberculosis report 2018 (WHO\/CDS\/TB\/2018.20). Geneva: World Health Organization; 2018. 243p. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274453\/9789241565646-eng.pdf?ua=1 . Accessed 23 Sep 2018."},{"key":"3508_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1590\/S1806-37132009001000011","volume":"35","author":"MB Conde","year":"2009","unstructured":"Conde MB, Melo FA, Marques AM, Cardoso NC, Pinheiro VG, Dalcin Pde T, et al. III Brazilian thoracic association guidelines on tuberculosis. J Bras Pneumol. 2009;35:1018\u201348.","journal-title":"J Bras Pneumol"},{"key":"3508_CR5","unstructured":"Minist\u00e9rio da Sa\u00fade (BR). Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2011. 288 p. (S\u00e9rie A. Normas e Manuais T\u00e9cnicos). http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_recomendacoes_controle_tuberculose_brasil.pdf . Accessed 05 Apr 2014."},{"key":"3508_CR6","unstructured":"Minist\u00e9rio da Sa\u00fade (BR). Indicadores. Boletim Epidemiol\u00f3gico - Secretaria de Vigil\u00e2ncia em Sa\u00fade - Minist\u00e9rio da Sa\u00fade. 2015;46(9):1\u201311. http:\/\/portalarquivos.saude.gov.br\/images\/pdf\/2015\/marco\/25\/Boletim-tuberculose-2015.pdf . Acessed 14 Jun 2018."},{"key":"3508_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1378\/chest.12-0142","volume":"142","author":"SK Sharma","year":"2012","unstructured":"Sharma SK, Mohanan S, Sharma A. Relevance of latent TB infection in areas of high TB prevalence. Chest. 2012;142:761\u201373.","journal-title":"Chest"},{"key":"3508_CR8","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018. p. 1\u201378p. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260233\/9789241550239-eng.pdf;jsessionid=EF4DDEDB879F6ADF516EB46BCC4AD932?sequence=1 . Acessed 14 Jun 2018."},{"key":"3508_CR9","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent mycobacterium tuberculosis infection. N Engl J Med. 2015;372:2127\u201335.","journal-title":"N Engl J Med"},{"key":"3508_CR10","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1164\/ajrccm\/148.5.1292","volume":"148","author":"BE Jones","year":"1993","unstructured":"Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1993;148:1292\u20137.","journal-title":"Am Rev Respir Dis"},{"key":"3508_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1590\/S1413-86702005000600004","volume":"9","author":"GB Klautau","year":"2005","unstructured":"Klautau GB, Kuschnaroff TM. Clinical forms and outcome of tuberculosis in HIV-infected patients in a tertiary hospital in S\u00e3o Paulo - Brazil. Braz J Infect Dis. 2005;9:464\u201378.","journal-title":"Braz J Infect Dis"},{"issue":"9","key":"3508_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/thorax.57.9.804","volume":"57","author":"L Wang","year":"2002","unstructured":"Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804\u20139. Erratum in: Thorax. 2003;58:188.","journal-title":"Thorax"},{"key":"3508_CR13","unstructured":"Minist\u00e9rio da Sa\u00fade (BR). Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de DST Aids e Hepatites Virais. Protocolo cl\u00ednico e diretrizes terap\u00eauticas para manejo da infec\u00e7\u00e3o pelo HIV em adultos. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2013. 75 p. http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/protocolo_clinico_manejo_hiv_adultos.pdf . Accessed 5 Apr 2014."},{"key":"3508_CR14","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States. 2010 MMWR Recomm Rep. 2010;59:1\u201325.","journal-title":"2010 MMWR Recomm Rep"},{"key":"3508_CR15","unstructured":"World Health Organization Global tuberculosis control: WHO report 2011 (WHO\/HTM\/TB\/2011.16). Geneva: World Health Organization; 2011. 246 p. http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241564380_eng.pdf . Accessed 5 Apr 2014."},{"key":"3508_CR16","unstructured":"World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011. p 52. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44472\/9789241500708_eng.pdf?sequence=1 . Accessed 5 Apr 2014."},{"key":"3508_CR17","unstructured":"World Health Organization. Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement (WHO\/HTM\/TB\/2011.18). Geneva: World Health Organization; 2011. 61 p. http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241502672_eng.pdf . Accessed 5 Apr 2014."},{"key":"3508_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"D Menzies","year":"2007","unstructured":"Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340\u201354.","journal-title":"Ann Intern Med"},{"key":"3508_CR19","unstructured":"World Health Organization Guidelines on the management of latent tuberculosis infection (WHO\/HTM\/TB\/2015.01). Geneva: World Health Organization;2015,38p. http:\/\/apps.who.int\/iris\/bitstream\/10665\/136471\/1\/9789241548908_eng.pdf?ua=1&ua=1 . Accessed 23 Feb 2016."},{"key":"3508_CR20","first-page":"603","volume":"119","author":"CE Rose Jr","year":"1979","unstructured":"Rose CE Jr, Zerbe GO, Lantz SO, Bailey WC. Establishing priority during investigation of tuberculosis contacts. Am Rev Respir Dis. 1979;119:603\u20139.","journal-title":"Am Rev Respir Dis"},{"key":"3508_CR21","unstructured":"WHO. WHO policy on collaborative TB\/HIV activities. Guidelines for national programmes and other stakeholders. Geneva, 2012;1\u201336p. https:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/Full_Report_3595.pdf"},{"issue":"2","key":"3508_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.chest.2017.11.018","volume":"153","author":"SK Field","year":"2018","unstructured":"Field SK, Escalante P, Fisher DA, Ireland B, Irwin RS. Cough due to TB and other chronic infections: CHEST guideline and expert panel report. Chest. 2018;153(2):467\u201397.","journal-title":"Chest"},{"key":"3508_CR23","first-page":"146","volume":"20","author":"M Mantoux","year":"1912","unstructured":"Mantoux M. La voie intradermique en tuberculinoth\u00e9rapie. Presse Med. 1912;20:146\u20138.","journal-title":"Presse Med"},{"issue":"1","key":"3508_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cyto.b.20068","volume":"68","author":"S Barbesti","year":"2005","unstructured":"Barbesti S, Soldini L, Carcelain G, Guignet A, Colizzi V, Mantelli B, et al. A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settings. Cytometry B Clin Cytom. 2005;68(1):43\u20135.","journal-title":"Cytometry B Clin Cytom"},{"key":"3508_CR25","doi-asserted-by":"crossref","unstructured":"Agresti A. Models for matched pairs. In: John Wiley & Sons, editors. An introduction to categorical data analysis. 2nd ed. New York; 2007. p. 244\u201375.","DOI":"10.1002\/9780470114759.ch8"},{"key":"3508_CR26","first-page":"CD000171","volume":"1","author":"C Akolo","year":"2010","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.","journal-title":"Cochrane Database Syst Rev"},{"key":"3508_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1164\/rccm.200610-1439OC","volume":"175","author":"MX Rangaka","year":"2007","unstructured":"Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med. 2007;175:514\u201320.","journal-title":"Am J Respir Crit Care Med"},{"key":"3508_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAD.0b013e328334895e","volume":"24","author":"BS Kabeer","year":"2010","unstructured":"Kabeer BS, Sikhamani R, Raja A. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS. 2010;24:323\u20135.","journal-title":"AIDS"},{"key":"3508_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","volume":"56","author":"A Cattamanchi","year":"2011","unstructured":"Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011;56:230\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3508_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1183\/09031936.00114810","volume":"37","author":"M Sester","year":"2011","unstructured":"Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011;37:100\u201311.","journal-title":"Eur Respir J"},{"key":"3508_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/resp.12002","volume":"18","author":"CB Chee","year":"2013","unstructured":"Chee CB, Sester M, Zhang W, Lange C. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis. Respirology. 2013;18:205\u201316.","journal-title":"Respirology"},{"key":"3508_CR32","doi-asserted-by":"publisher","first-page":"e8257","DOI":"10.1371\/journal.pone.0008257","volume":"4","author":"H del Corral","year":"2009","unstructured":"del Corral H, Par\u00eds SC, Mar\u00edn ND, Mar\u00edn DM, L\u00f3pez L, Henao HM, et al. IFNgamma response to Mycobacterium tuberculosis, Risk of infection and disease in house hold contacts of tuberculosis patients in Colombia. PLoS One. 2009;4:e8257.","journal-title":"PLoS One"},{"key":"3508_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/325295","volume":"2011","author":"A Fujita","year":"2011","unstructured":"Fujita A, Ajisawa A, Harada N, Higuchi K, Mori T. Performance of a whole-blood interferon-gamma release assay with mycobacterium RD1-specific antigens among HIV-infected persons. Clin Dev Immunol. 2011;2011:325295.","journal-title":"Clin Dev Immunol"},{"key":"3508_CR34","unstructured":"Minist\u00e9rio da Sa\u00fade (BR) Secretaria de Vigil\u00e2ncia em Sa\u00fade. Nota Informativa n\u00b0 11\/2018-.DIAHV\/SVS\/MS. Recomenda\u00e7\u00f5es para tratamento da Infec\u00e7\u00e3o Latente por Tuberculose (ILTB) em pessoas vivendo com HIV (PVHIV). 2018. 4p. https:\/\/drive.google.com\/file\/d\/1YQuovBq8UGSJlROgw-kRD7UMeVzc2Ezz\/view . Accessed 16 Jun 2018."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3508-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3508-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3508-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T08:08:41Z","timestamp":1694074121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3508-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3508"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3508-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"15 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institucional Review Board of Instituto de Infectologia Emilio Ribas, 073\/2011; Institucional Review Board of Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo, 023\/11; Institucional Review Board of Universidade Federal de S\u00e3o Paulo (UNIFESP) and by Instituto Clemente Ferreira, CEP 0325\/11. Before enrollment, all participants received a brief explanation of the aims, risks and benefits of the present study in each Institution from which patients were recruited. The participants signed an informed consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"585"}}